Ticker: BSPM, Company: Biostar Pharmaceuticals, Inc., Type: 8-K, Date: 2010-07-06
Original SEC Filing: Click here

---

Webplus: BSPM/20100706/8-K/2_EX-99.1/000.htm SEC Original: ex99-1.htm
BIOSTAR PHARMACEUTICALS, APPOINTS NEW CHIEF FINANCIAL OFFICER XIANYANG, China, July 6, 2010 (Xinhua-PRNewswire-FirstCall) Mr. Chen brings more than 13 years of multinational and Big 4 accounting experiences to Biostar.His expertiseludes financial management, financing transactions,rporate governance and investor relations.Most recently, Mr. Chen was an independentvisor engaged in local RMB PE fundraising and providing M&A and PEvisory

---

---

Webplus: BSPM/20100706/8-K/1/000.htm SEC Original: biostar8k070610.htm
FORM 8-K CURRENT REPORTte of report (Date of earliest event reported): July 6, 2010 BIOSTAR PHARMACEUTICALS, Maryland 001-34708 20-8747899 (State or other jurisdiction oforporation or organization) (Commission File No.) (IRS Employer Identification No.) No. 588 Shiji Avenue Xiangyang City, Shaanxi Province Peoples Republic of China 712046 86-029-33686638 (Issuer Telephone Number)

---

Company Information:

Ticker: BSPM, Company: Biostar Pharmaceuticals, Inc., Type: 8-K, Date: 2010-07-06CIK: 0001418133, Location: F4, SIC: 2834, SIC Desc: PHARMACEUTICAL PREPARATIONS
Business Phone & Address:
NO. 588 SHIJI XI AVENUE
XIANYANG, SHAANXI PROVINCE 712046